Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX vs XELOX plus Chemoradiotherapy in D2-Resected Gastric Cancer
NCT01711242Phase 2Completed
- Start
- Jan 2012
- Primary completion
- Jan 2020
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in gastric adenocarcinoma. Started Jan 2012; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01711242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711242.